Kim DK - Search Results

1

Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.

Lee JE, Lee P, Yoon YC, Han BS, Ko S, Park MS, Lee YJ, Kim SE, Cho YJ, Lim JH, Ryu JK, Shim S, Kim DK, Jung KH, Hong SS. Lee JE, et al. Among authors: kim se, kim dk. Biomed Pharmacother. 2023 Jun;162:114716. doi: 10.1016/j.biopha.2023.114716. Epub 2023 Apr 20. Biomed Pharmacother. 2023. PMID: 37086509 Free article.

2

Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis.

Ha KB, Lee ES, Park NW, Jo SH, Shim S, Kim DK, Ahn CM, Chung CH. Ha KB, et al. Among authors: kim dk. Diabetes Metab J. 2023 Jul;47(4):500-513. doi: 10.4093/dmj.2022.0110. Epub 2023 Apr 25. Diabetes Metab J. 2023. PMID: 37096379 Free PMC article.

3

IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease.

Ryu JK, Piao S, Shin HY, Choi MJ, Zhang LW, Jin HR, Kim WJ, Han JY, Hong SS, Park SH, Lee SJ, Kim IH, Lee CR, Kim DK, Mamura M, Kim SJ, Suh JK. Ryu JK, et al. Among authors: kim ih, kim wj, kim dk, kim sj. J Sex Med. 2009 May;6(5):1284-96. doi: 10.1111/j.1743-6109.2009.01216.x. Epub 2009 Mar 18. J Sex Med. 2009. PMID: 19473283

4

EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation.

Ha KB, Sangartit W, Jeong AR, Lee ES, Kim HM, Shim S, Kukongviriyapan U, Kim DK, Lee EY, Chung CH. Ha KB, et al. Among authors: kim hm, kim dk. Endocrinol Metab (Seoul). 2022 Feb;37(1):96-111. doi: 10.3803/EnM.2021.1305. Epub 2022 Feb 28. Endocrinol Metab (Seoul). 2022. PMID: 35255604 Free PMC article.

5

Different routes of administering EW-7197 versus EW-7197⋅HBr for preventing peritoneal adhesion in a rat model.

Zeng CH, Kim SH, Kang JM, Park Y, Won DS, Kim JW, Ryu DS, Shim S, Kim DK, Shin JH, Park JH. Zeng CH, et al. Among authors: kim sh, kim dk, kim jw. Surgery. 2023 Apr;173(4):1008-1014. doi: 10.1016/j.surg.2022.11.016. Epub 2022 Dec 26. Surgery. 2023. PMID: 36577598

6

Discovery of (E)-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis.

Shim S, Krishnaiah M, Sankham MR, Kim I, Lee Y, Shin I, Oh AR, Lee HJ, Vu TNL, Park J, Choi S, Park S, Kwon Y, Fang S, Kim DK. Shim S, et al. Among authors: kim dk, kim i. J Med Chem. 2022 Jul 28;65(14):9974-10000. doi: 10.1021/acs.jmedchem.2c00641. Epub 2022 Jul 7. J Med Chem. 2022. PMID: 35797110

7

An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.

Park CY, Min KN, Son JY, Park SY, Nam JS, Kim DK, Sheen YY. Park CY, et al. Among authors: kim dk. Cancer Lett. 2014 Aug 28;351(1):72-80. doi: 10.1016/j.canlet.2014.05.006. Epub 2014 Jun 2. Cancer Lett. 2014. PMID: 24887560

8

EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.

Park CY, Kim DK, Sheen YY. Park CY, et al. Among authors: kim dk. Cancer Sci. 2011 Oct;102(10):1889-96. doi: 10.1111/j.1349-7006.2011.02014.x. Epub 2011 Jul 29. Cancer Sci. 2011. PMID: 21707864 Free article.

9

TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition.

Kim MJ, Park SA, Kim CH, Park SY, Kim JS, Kim DK, Nam JS, Sheen YY. Kim MJ, et al. Among authors: kim ch, kim dk, kim js. Cell Physiol Biochem. 2016;38(2):571-88. doi: 10.1159/000438651. Epub 2016 Feb 5. Cell Physiol Biochem. 2016. PMID: 26845171 Free article.

10

Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer.

Joung KE, Min KN, Kim DK, Sheen YY. Joung KE, et al. Among authors: kim dk. Biomol Ther (Seoul). 2012 Jan;20(1):81-8. doi: 10.4062/biomolther.2012.20.1.081. Biomol Ther (Seoul). 2012. PMID: 24116279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,819 results

Search Page